Treatment strategies for chronic and refractory obsessive-compulsive disorder.
Obsessive-compulsive disorder (OCD), despite our increasing understanding of its causes and its effective treatment, remains a chronic and underdiagnosed disorder. Both treatment with SSRIs and the behavioral treatment strategy of exposure with response prevention have been proved by clinical trials to be effective and safe in treating OCD; however, even these treatments sometimes elicit only moderate patient response, and some OCD patients do not respond to them at all. Preliminary data suggest that OCD has lifelong persistence and that discontinuation of pharmacotherapy often leads to relapse. Nonetheless, further prospective, controlled, maintenance studies of OCD are needed to determine factors in and predictors of recovery, remission, and relapse. Finally, new procedures for treatment-refractory patients are needed; neurosurgical and new pharmacologic approaches have shown promise in treating these patients and should be studied in controlled trials.
Rasmussen
S A
SA
Department of Psychiatry and Human Behavior, Brown University School of Medicine, Providence, R.I. 02906, USA.
Eisen
J L
JL
D001521:Behavior Therapy; D001921:Brain / Q000601:surgery; D002908:Chronic Disease; D003131:Combined Modality Therapy; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D012008:Recurrence; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013238:Stereotaxic Techniques; D016896:Treatment Outcome
D017367:Selective Serotonin Reuptake Inhibitors